Elderly US patients not receiving chemo for AML
Added: Tuesday 31 January 2012
A recent analysis suggests that over half of elderly patients with acute myeloid leukaemia (AML) are not receiving any chemotherapy. The research found that median survival as well as chemotherapy use declined with advancing age.
In order to be able to see the content from the www.medscape.com pages, please create first a free account at following link: